RECOMBINANT HUMAN EPO-FC FUSION PROTEINS WITH PROLONGED HALF-LIFE AND ENHANCED ERYTHROPOIETIC ACTIVITY IN VIVO

RECOMBINANT HUMAN EPO-FC FUSION PROTEINS WITH PROLONGED HALF-LIFE AND ENHANCED ERYTHROPOIETIC ACTIVITY IN VIVO

  • CN 102,816,242 A
  • Filed: 01/25/2007
  • Published: 12/12/2012
  • Est. Priority Date: 01/27/2006
  • Status: Active Application
First Claim
Patent Images

1. comprise the recombination fusion protein that is connected directly to the segmental rHuEPO molecule of human IgG Fc, wherein said fusion rotein has the transformation period in the body of comparing natural human erythropoietin prolongation natural generation or reorganization.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×